Printer Friendly

SYNTRO ANNOUNCES PUBLIC OFFERING OF STOCK

 SYNTRO ANNOUNCES PUBLIC OFFERING OF STOCK
 KANSAS CITY, Mo., April 16 /PRNewswire/ -- Syntro Corporation


(NASDAQ: SYNT) announced today that its registration statement has become effective and a public offering of 1,450,000 shares of common stock at $4.50 per share is being made through its underwriters Piper Jaffray & Hopwood and George K. Baum and Company.
 Syntro Corporation is a Kansas City and San Diego based biotechnology company engaged in the development and commercialization of genetically engineered vaccines for the animal health sector. SyntroVet Incorporated, a wholly owned subsidiary, manufactures and markets products resulting from Syntro's research and collaborative efforts.
 -0- 4/16/92
 /CONTACT: J. Donald Todd of Syntro Corporation, 913-888-8876; or Jack Falker of Swenson Falker Eilertsen, 612-371-0000/
 (SYNT) CO: Syntro Corporation ST: Minnesota IN: MTC SU: OFR


KH -- MN009 -- 9239 04/16/92 11:27 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 16, 1992
Words:140
Previous Article:BUCKEYE PARTNERS L.P. ANNOUNCES EARNINGS
Next Article:SPS REPORTS INCREASE IN FIRST QUARTER REVENUES NET INCOME MARKS COMPANY RECORD


Related Articles
SYNTRO INTENDS TO FILE REGISTRATION STATEMENT
SYNTRO REPORTS FIRST QUARTER PROFIT
SYNTRO AND HOECHST TO DEVELOP VACCINES
SYNTRO FILES REGISTRATION STATEMENT FOR PUBLIC OFFERING OF 3,000,000 SHARES
SYNTRO REPORTS SECOND QUARTER EARNINGS
SYNTRO REPORTS THIRD QUARTER EARNINGS
SUSAN STROBEL TO JOIN SYNTRO AS VICE PRESIDENT OF FINANCE AND CFO
MALLINCKRODT TO MAKE TENDER OFFER FOR SYNTRO CORPORATION STOCK
MALLINCKRODT GROUP ANNOUNCES TENDER OFFER FOR SYNTRO CORP

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters